{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:29:32Z","timestamp":1779114572078,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["25K02477"],"award-info":[{"award-number":["25K02477"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"DOI":"10.1007\/s00383-025-06255-9","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:35:15Z","timestamp":1764844515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of CD7 as a novel biomarker of embryonal hepatoblastoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Ahmad","family":"Adawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohsuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiso","family":"Hiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taizo","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"1","key":"6255_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12943-025-02405-8","volume":"24","author":"J Yang","year":"2025","unstructured":"Yang J, Davidoff AM, Murphy AJ (2025) From preneoplastic lesion to heterogenous tumor: recent insights into hepatoblastoma biology and therapeutic opportunities. Mol Cancer 24(1):198. https:\/\/doi.org\/10.1186\/s12943-025-02405-8","journal-title":"Mol Cancer"},{"issue":"1","key":"6255_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","volume":"26","author":"P Czauderna","year":"2014","unstructured":"Czauderna P, Lopez-Terrada D, Hiyama E et al (2014) Hepatoblastoma state of the art: Pathology, genetics, risk stratification, and chemotherapy. Curr Opin Pediatr 26(1):19\u201328. https:\/\/doi.org\/10.1097\/MOP.0000000000000046","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"6255_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.surg.2020.12.035","volume":"170","author":"IA Ziogas","year":"2021","unstructured":"Ziogas IA, Benedetti DJ, Wu WK et al (2021) Management of hepatoblastoma in the united states: can we do better? Surgery 170(2):579\u2013586. https:\/\/doi.org\/10.1016\/j.surg.2020.12.035","journal-title":"Surgery"},{"issue":"4","key":"6255_CR4","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1002\/cam4.5300","volume":"12","author":"M Honda","year":"2023","unstructured":"Honda M, Uchida K, Irie T et al (2023) Recent advances in surgical strategies and liver transplantation for hepatoblastoma. Cancer Med 12(4):3909\u20133918. https:\/\/doi.org\/10.1002\/cam4.5300","journal-title":"Cancer Med"},{"issue":"3","key":"6255_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/SLA.0000000000004071","volume":"273","author":"G Sapisochin","year":"2021","unstructured":"Sapisochin G, Hibi T, Toso C et al (2021) Transplant oncology in primary and metastatic liver tumors: Principles, Evidence, and opportunities. Ann Surg 273(3):483\u2013493. https:\/\/doi.org\/10.1097\/SLA.0000000000004071","journal-title":"Ann Surg"},{"issue":"1","key":"6255_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.17998\/jlc.2022.02.24","volume":"22","author":"S Jeong","year":"2022","unstructured":"Jeong S, Kang H (2022) Recent updates on the classification of hepatoblastoma according to the international pediatric liver tumors consensus. J Liver Cancer 22(1):23\u201329. https:\/\/doi.org\/10.17998\/jlc.2022.02.24","journal-title":"J Liver Cancer"},{"key":"6255_CR7","doi-asserted-by":"publisher","unstructured":"Sheng B, Zhang K, Tian S et al (2023) CD7 protein plays a crucial role in T cell infiltration in tumors. Heliyon 9. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16961","DOI":"10.1016\/j.heliyon.2023.e16961"},{"issue":"2","key":"6255_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10495-005-0801-y","volume":"10","author":"S Nakahara","year":"2005","unstructured":"Nakahara S, Oka N, Raz A (2005) On the role of galectin-3 in cancer apoptosis. Apoptosis 10(2):267\u2013275. https:\/\/doi.org\/10.1007\/s10495-005-0801-y","journal-title":"Apoptosis"},{"issue":"1","key":"6255_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1309\/48KC17WAU69BTBXQ","volume":"120","author":"PG Chu","year":"2003","unstructured":"Chu PG, Arber DA, Weiss LM (2003) Expression of T\/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms: an immunohistochemical study of 447 cases. Am J Clin Pathol 120(1):64\u201370. https:\/\/doi.org\/10.1309\/48KC17WAU69BTBXQ","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"6255_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00292-006-0836-z","volume":"27","author":"F L\u00e4nger","year":"2006","unstructured":"L\u00e4nger F, von Wasielewski R, Kreipe HH (2006) The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas. Pathologe 27(4):244\u2013250. https:\/\/doi.org\/10.1007\/s00292-006-0836-z","journal-title":"Pathologe"},{"issue":"1","key":"6255_CR11","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1080\/21655979.2021.1924546","volume":"12","author":"Z Xiang","year":"2021","unstructured":"Xiang Z, Shen E, Li M et al (2021) Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy. Bioengineered 12(1):1773\u20131790. https:\/\/doi.org\/10.1080\/21655979.2021.1924546","journal-title":"Bioengineered"},{"issue":"4","key":"6255_CR12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/jid.2013.437","volume":"134","author":"T Wang","year":"2014","unstructured":"Wang T, Ge Y, Xiao M et al (2014) SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway. J Invest Dermatol 134(4):1108\u20131118. https:\/\/doi.org\/10.1038\/jid.2013.437","journal-title":"J Invest Dermatol"},{"issue":"1","key":"6255_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ymthe.2022.09.003","volume":"31","author":"N Watanabe","year":"2023","unstructured":"Watanabe N, Mo F, Zheng R et al (2023) Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies. Mol Ther 31(1):24\u201334. https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.003","journal-title":"Mol Ther"},{"issue":"4","key":"6255_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","volume":"43","author":"B Du","year":"2025","unstructured":"Du B, Qin J, Lin B et al (2025) CAR-T therapy in solid tumors. Cancer Cell 43(4):665\u2013679. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.019","journal-title":"Cancer Cell"},{"issue":"45","key":"6255_CR15","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1038\/onc.2012.543","volume":"32","author":"BC Bisikirska","year":"2013","unstructured":"Bisikirska BC, Adam SJ, Alvarez MJ et al (2013) STK38 is a critical upstream regulator of myc\u2019s oncogenic activity in human B-cell lymphoma. Oncogene 32(45):5283\u20135291. https:\/\/doi.org\/10.1038\/onc.2012.543","journal-title":"Oncogene"},{"key":"6255_CR16","doi-asserted-by":"publisher","first-page":"624079","DOI":"10.3389\/fonc.2020.624079","volume":"10","author":"J Otte","year":"2021","unstructured":"Otte J, Dyberg C, Pepich A, Johnsen JI (2021) MYCN function in neuroblastoma development. Front Oncol 10:624079. https:\/\/doi.org\/10.3389\/fonc.2020.624079","journal-title":"Front Oncol"},{"issue":"1","key":"6255_CR17","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1038\/s41467-023-39717-6","volume":"14","author":"J Fang","year":"2023","unstructured":"Fang J, Singh S, Cheng C et al (2023) Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma. Nat Commun 14(1):4003. https:\/\/doi.org\/10.1038\/s41467-023-39717-6","journal-title":"Nat Commun"},{"issue":"10","key":"6255_CR18","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejca.2011.12.011","volume":"48","author":"R Maibach","year":"2012","unstructured":"Maibach R, Roebuck D, Brugieres L et al (2012) Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer 48(10):1543\u20131549. https:\/\/doi.org\/10.1016\/j.ejca.2011.12.011","journal-title":"Eur J Cancer"},{"issue":"1","key":"6255_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/children6010001","volume":"6","author":"IIP Lim","year":"2018","unstructured":"Lim IIP, Bondoc AJ, Geller JI et al (2018) Hepatoblastoma\u2014the evolution of biology, surgery, and transplantation. Children 6(1):1. https:\/\/doi.org\/10.3390\/children6010001","journal-title":"Children"},{"issue":"1","key":"6255_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin P, Chen Y, Trevi\u00f1o LR et al (2017) Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65(1):104\u2013121. https:\/\/doi.org\/10.1002\/hep.28888","journal-title":"Hepatology"},{"issue":"2","key":"6255_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/hep.29844","volume":"68","author":"W Zhu","year":"2018","unstructured":"Zhu W, Peng Y, Wang L et al (2018) Identification of \u03b1-Fetoprotein-Specific T-Cell receptors for hepatocellular carcinoma immunotherapy HHS public access. Hepatology 68(2):574\u2013589. https:\/\/doi.org\/10.1002\/hep.29844","journal-title":"Hepatology"},{"issue":"8","key":"6255_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/003655202760230928","volume":"37","author":"P Hanke","year":"2002","unstructured":"Hanke P, Rabe C, Serwe M et al (2002) Cirrhotic patients with or without hepatocellular carcinoma harbour AFP-specific T-lymphocytes that can be activated in vitro by human alpha-fetoprotein. Scand J Gastroenterol 37(8):949\u2013955. https:\/\/doi.org\/10.1080\/003655202760230928","journal-title":"Scand J Gastroenterol"},{"key":"6255_CR23","doi-asserted-by":"publisher","first-page":"1363695","DOI":"10.3389\/fonc.2024.1363695","volume":"14","author":"Y Lu","year":"2024","unstructured":"Lu Y, Lin B, Li M (2024) The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma. Front Oncol 14:1363695. https:\/\/doi.org\/10.3389\/fonc.2024.1363695","journal-title":"Front Oncol"},{"issue":"6","key":"6255_CR24","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3390\/jcm12062326","volume":"12","author":"M Kulczycka","year":"2023","unstructured":"Kulczycka M, Derlatka K, Tasior J et al (2023) CAR T-Cell therapy in children with solid tumors. J Clin Med 12(6):2326. https:\/\/doi.org\/10.3390\/jcm12062326","journal-title":"J Clin Med"},{"key":"6255_CR25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.3389\/fimmu.2018.02380","volume":"9","author":"RM Richards","year":"2018","unstructured":"Richards RM, Sotillo E, Majzner RG (2018) CAR T cell therapy for neuroblastoma. Front Immunol 9:2380. https:\/\/doi.org\/10.3389\/fimmu.2018.02380","journal-title":"Front Immunol"},{"key":"6255_CR26","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.ejcped.2024.100179","volume":"4","author":"J Anderson","year":"2024","unstructured":"Anderson J, Barone G, Zehner A (2024) GD2 targeting CAR T cells for neuroblastoma. EJC Paediatr Oncol 4:100179. https:\/\/doi.org\/10.1016\/j.ejcped.2024.100179","journal-title":"EJC Paediatr Oncol"},{"issue":"4","key":"6255_CR27","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41591-025-03513-0","volume":"31","author":"CH Li","year":"2025","unstructured":"Li CH, Sharma S, Heczey AA et al (2025) Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma. Nat Med 31(4):1125\u20131129. https:\/\/doi.org\/10.1038\/s41591-025-03513-0","journal-title":"Nat Med"},{"issue":"1","key":"6255_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","volume":"22","author":"AA Getu","year":"2023","unstructured":"Getu AA, Tigabu A, Zhou M et al (2023) New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Mol Cancer 22(1):43. https:\/\/doi.org\/10.1186\/s12943-023-01751-9","journal-title":"Mol Cancer"},{"issue":"1","key":"6255_CR29","doi-asserted-by":"publisher","first-page":"e010083","DOI":"10.1136\/jitc-2024-010083","volume":"13","author":"T Inthanachai","year":"2025","unstructured":"Inthanachai T, Boonkrai C, Phakham T et al (2025) Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study. J Immunother Cancer 13(1):e010083. https:\/\/doi.org\/10.1136\/jitc-2024-010083","journal-title":"J Immunother Cancer"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-025-06255-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-025-06255-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-025-06255-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:35:16Z","timestamp":1764844516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-025-06255-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6255"],"URL":"https:\/\/doi.org\/10.1007\/s00383-025-06255-9","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Informed consent for participation in the study was obtained from the patients\u2019 caregivers. The protocol of this study was approved by the Institutional Review Board (IRB) of Kumamoto University (IRB No. 2927), as well as the ethics committee of Kanazawa Medical University (IRB No. 1367).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"30"}}